NCT-501
NCT-501 is a potent and selective theophylline-based inhibitor of aldehyde dehydrogenase 1A1 (ALDH1A1), inhibits hALDH1A1 with IC50 of 40 nM, typically shows better selectivity over other ALDH isozymes and other dehydrogenases (hALDH1B1, hALDH3A1, and hALDH2, IC50 >57 μM) .
Product Specifications
CAS Number
1802088-50-1
UNSPSC
12352005
Target
Aldehyde Dehydrogenase (ALDH)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/NCT-501.html
Purity
99.59
Solubility
DMSO : 3.57 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(N1C)N(C)C2=C(N(CCC(C)C)C(CN3CCN(C(C4CC4)=O)CC3)=N2)C1=O
Molecular Formula
C21H32N6O3
Molecular Weight
416.52
References & Citations
[1]Kulsum S et al. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by Aldehydedehydrogenase 1 A1 inhibition.
 Mol Carcinog. 2016 Jul 6.|[2]Yang SM, et al. Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1) . J Med Chem. 2015 Aug 13;58 (15) :5967-5978.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ALDH1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![eNOS (NOS3) pSer1177 Mouse Monoclonal Antibody [Clone ID: 15E2]](https://cdn.genprice.uk/products/937/68dd1899061270361e8fb621/imageurl/am00098pu-n.webp)
AM00098PU-N 100 µg
eNOS (NOS3) pSer1177 Mouse Monoclonal Antibody [Clone ID: 15E2]
Sign In for Pricing
View Details 
PKSM041221-01 10 µg
Recombinant Mouse XEDAR/EDA2R Protein (His Tag)
Sign In for Pricing
View Details PKSM041221-02 50 µg
Recombinant Mouse XEDAR/EDA2R Protein (His Tag)
Sign In for Pricing
View Details 
TRC-B443750-50MG 50 mg
Bis(heptadecafluorooctyl)phosphinic Acid Sodium Salt
Sign In for Pricing
View Details 